Suraksha Diagnostic Ltd
Q1 FY27, unaudited
- Revenue
- ₹87.65 Cr
- Profit after tax
- ₹12.85 Cr
As filed with the exchange, consolidated basis.
Statement of profit and loss
Figures in ₹ crore, reproduced from the results data files the company filed with NSE under Regulation 33 of the SEBI (LODR) Regulations. Nothing is restated, adjusted or estimated.
| ₹ crore | Q1 FY27 | vs a year ago | FY26 |
|---|---|---|---|
| Revenue from operations | 87.65 | +20.75% | 310.41 |
| Other income | 1.09 | +20.09% | 3.16 |
| Total income | 88.73 | +20.74% | 313.58 |
| Employee benefit expense | 14.41 | +12.82% | 53.26 |
| Finance costs | 3.72 | +37.61% | 12.55 |
| Depreciation & amortisation | 11.28 | +18.98% | 41.45 |
| Total expenses | 72.21 | +18.33% | 269.02 |
| Profit before tax | 16.53 | +32.54% | 44.56 |
| Tax expense | 3.68 | +11.74% | 13.15 |
| Profit after tax | 12.85 | +40.00% | 31.40 |
| Total comprehensive income | 12.99 | +38.61% | 31.97 |
| Earnings per share, basic | ₹2.50 | ₹6.18 |
|---|---|---|
| Earnings per share, diluted | ₹2.50 | ₹6.18 |
Earnings call
Q1 FY27Suraksha Diagnostic reported Q1 FY'27 total income of Rs 887 million, up 21% year-on-year, with EBITDA growing 28% to Rs 315 million and PAT growing 40% to Rs 128 million. The company added one hub and three spoke centres during the quarter, taking its network to 72 centres, and management said centres under two years old turned EBITDA-positive for the first time at 6.5% margin. Management also discussed continued growth in the Suraksha Genomics vertical, which posted revenue of Rs 13.7 million, up 136% year-on-year.
Generated by AI from the filed transcript; every statement on the full page carries its verbatim quote.
Earlier calls: Q4 FY26 · All quarters
Filings
12 shown · 41 published by the exchange
05 Oct 2026
28 Sept 2026
Insider trading24 Sept 2026
23 Sept 2026
22 Sept 2026
31 Aug 2026
Filing27 Aug 2026
27 Aug 2026
27 Aug 2026
25 Aug 2026
17 Aug 2026
Transcript13 Aug 2026
BSE corporate announcements, classified by Parakho. The exchange’s own category is kept alongside our classification so a reclassification never rewrites history.
Industry
Healthcare › Healthcare Service Provider
Classification as published by BSE.
Companies also in Healthcare Service Provider, in alphabetical order
Page generated from filings held to 05 Oct 2026.